THE DARWIN CENTRE FOR BIOLOGY AND MEDICINEActive

Company number 02850118Private company limited by guaranteeIncorporated 1993

Key figures

£104,369-2.6%
Net assets 2024/25
-1.5%
Average annual change 2019/20–2024/25
050 k100 k150 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, THE DARWIN CENTRE FOR BIOLOGY AND MEDICINE does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k150 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand122,263————
Total assets—97,50597,004107,190104,369
Total liabilities00000
Net assets / total equity122,26397,50597,004107,190104,369
Average number of employees32222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: THE DARWIN CENTRE FOR BIOLOGY AND MEDICINE

Company

THE DARWIN CENTRE FOR BIOLOGY AND MEDICINE is a private company limited by guarantee registered with Companies House under company number 02850118. It was incorporated on 2 Sep 1993. Its status is active. The registered office is in Haverfordwest (SA61). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110), other research and experimental development on natural sciences and engineering (72190), other education n.e.c. (85590).

Accounts

The latest accounts in the database are for 2024/25 (period ending 28 Jul 2025); the company files micro-entity accounts. Net assets were £104,369, down 2.6% on the previous year. Total assets were £104,369 and total liabilities £0. The company had an average of 2 employees. Figures are available for 6 financial years (2019/20–2024/25).

Filing deadlines

The next accounts are due by 28 Apr 2027. The next confirmation statement is due by 16 Sep 2027.